Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer

Ovarian cancer is routinely treated with surgery and platinum‐based chemotherapy. Resistance is a major obstacle in the efficacy of this chemotherapy regimen and the ability to identify those patients at risk of developing resistance is of considerable clinical importance. The expression of calpain‐1, calpain‐2 and calpastatin were determined using standard immunohistochemistry on a tissue microarray of 154 primary ovarian carcinomas from patients subsequently treated with platinum‐based adjuvant chemotherapy. High levels of calpain‐2 expression was significantly associated with platinum resistant tumours (P = 0.031). Furthermore, high expression of calpain‐2 was significantly associated with progression‐free (P = 0.049) and overall survival (P = 0.006) in this cohort. The association between calpain‐2 expression and overall survival remained significant in multivariate analysis accounting for tumour grade, stage, optimal debulking and platinum sensitivity (hazard ratio = 2.174; 95% confidence interval = 1.144–4.130; P = 0.018). The results suggest that determining calpain‐2 expression in ovarian carcinomas may allow prognostic stratification of patients treated with surgery and platinum‐based chemotherapy. The findings of this study warrant validation in a larger clinical cohort.     

Enzyme Responses of <Emphasis Type="Italic">Abutilon Theophrasti</Emphasis> in an Enhanced Biocontrol System

Weak virulence has limited the development of Colletorichum coccodes (Wallr.) Hughes (DAOM 183088) as a bioherbicide for Abutilon theophrasti Medik. (velvetleaf) control. This study examines the role of chemical synergy to suppress host defense mechanisms. Dry weight of A. theophrasti was reduced by treatment with C. coccodes in a tank-mix with 0.25 kg a.i. ha⁻¹ bentazon more than by the treatment with C. coccodes or bentazon alone, while the effect of a sub-lethal rate of glyphosate was not significant. C. coccodes did not affect phenylalanine ammonia lyase (PAL) activity in infected leaves of A. theophrasti, whereas PAL activity was significantly inhibited by the presence of bentazon 5 days after treatment. The inhibition was stronger when bentazon was applied alone than when bentazon was applied with C. coccodes. Treatment with glyphosate or a mixture of glyphosate and C. coccodes did not affect PAL activity. Peroxidase activity was strongly induced by C. coccodes treatment and increased over time. Peroxidase activity was not induced by 0.25 kg a.i. ha⁻¹ bentazon alone. However, when bentazon was applied in combination with C. coccodes, it prevented the activation of peroxidase by C. coccodes infection. Treatment with 0.2 kg a.i. ha⁻¹ glyphosate did not affect peroxidase activity. These results suggest that these enzymes are involved in the resistance mechanism of A. theophrasti, and the synergistic effect of bentazon on C. coccodes efficacy as a bioherbicide may result from suppressing the activation of these defense-related enzymes.     

Molecular cloning,characterization, and expression of a cDNA encoding an endochitinase gene from the mycoparasite Stachybotrys elegans

Stachybotrys elegans is a mycoparasite of the soilborne plant pathogenic fungus Rhizoctonia solani. The mycoparasitic activity of S. elegans is correlated with the production of cell wall degrading enzymes such as chitinases. This report details the cloning by RACE-PCR and characterization of a full-length cDNA clone, sechi44, that appears to encode an extracellular endochitinase. An analysis of the sechi44 sequence indicates that this gene contains a 1269-bp ORF and encodes a 423-aa polypeptide. The SECHI44 protein has a calculated molecular weight of 44.1kDa and pI of 5.53. Since the SECHI44 protein also appears to encode a signal peptide, an extracellular location for the corresponding protein is predicted. Comparison of SECHI44 sequence with known sequences of fungal endochitinases revealed that SECHI44 is grouped with endochitinases from other mycoparasites. Real-time quantitative RT-PCR analysis showed an elevated level of expression of sechi44 (21-fold) in chitin-rich (induced) as compared to no-carbon (non-induced) culture conditions. In dual culture, the temporal expression of sechi44 increased after 2 days of contact with R. solani, reaching a 10-fold increase after 9 days, followed by a decrease to basic expression level at 12 days. Interestingly, inhibition of sechi44 expression was observed when S. elegans hyphae were in close proximity with R. solani hyphae.     

Purification and characterization of an extracellular exochitinase,beta-N-acetylhexosaminidase,from the fungal mycoparasite Stachybotrys elegans

The mycoparasite Stachybotrys elegans produces two exo- and one endo-acting chitinases when grown on chitin. We purified to homogeneity one of the exo-acting chitinases, beta-N-acetylhexosaminidase and partially characterized its physical and biochemical properties. The native enzyme has a molecular mass of 120 kDa when determined by gel filtration and 68 kDa by sodium dodecyl sulfate - polyacrylamide gel electrophoresis indicating that the native protein probably occurs as a dimer in solution. The purified beta-N-acetylhexosaminidase is most active at pH 5.0 and 40 degrees C and hydrolyzes the p-nitrophenyl-N-acetyl-beta-D-glucosaminide with apparent Km of 84.6 microM. Polyclonal antibodies raised against the 68-kDa beta-N-acetylhexosaminidase (NAG-68) indicated that the antibody is highly specific and recognizes the protein in crude filtrate preparation. This suggests that the protein is a not a proteolytic product of another protein. Western blot analysis showed that the activity of NAG-68 was induced when S. elegans was grown on purified cell wall fragments of its host, Rhizoctonia solani, as well as during antagonistic interaction of the mycoparasite and host when both were grown on synthetic medium with or without supplemental carbon source.     

An In-Depth Comparison of Latent HIV-1 Reactivation in Multiple Cell Model Systems and Resting CD4+ T Cells from Aviremic Patients

The possibility of HIV-1 eradication has been limited by the existence of latently infected cellular reservoirs. Studies to examine control of HIV latency and potential reactivation have been hindered by the small numbers of latently infected cells found in vivo. Major conceptual leaps have been facilitated by the use of latently infected T cell lines and primary cells. However, notable differences exist among cell model systems. Furthermore, screening efforts in specific cell models have identified drug candidates for “anti-latency” therapy, which often fail to reactivate HIV uniformly across different models. Therefore, the activity of a given drug candidate, demonstrated in a particular cellular model, cannot reliably predict its activity in other cell model systems or in infected patient cells, tested ex vivo. This situation represents a critical knowledge gap that adversely affects our ability to identify promising treatment compounds and hinders the advancement of drug testing into relevant animal models and clinical trials. To begin to understand the biological characteristics that are inherent to each HIV-1 latency model, we compared the response properties of five primary T cell models, four J-Lat cell models and those obtained with a viral outgrowth assay using patient-derived infected cells. A panel of thirteen stimuli that are known to reactivate HIV by defined mechanisms of action was selected and tested in parallel in all models. Our results indicate that no single in vitro cell model alone is able to capture accurately the ex vivo response characteristics of latently infected T cells from patients. Most cell models demonstrated that sensitivity to HIV reactivation was skewed toward or against specific drug classes. Protein kinase C agonists and PHA reactivated latent HIV uniformly across models, although drugs in most other classes did not.